相关实验视频
Updated: Jan 31, 2026

07:51
Pull-down of Calmodulin-binding Proteins
Published on: January 23, 2012
25.9K
生物催化四甲通过密码性青素结合蛋白类型thioesterases进行宏循环
Paisley L Jeannette1, Zachary L Budimir1, Lucas O Johnson1
1James Tarpo Jr. and Margaret Tarpo Department of Chemistry, Purdue University, West Lafayette, Indiana 47906, United States.
Biochemistry
|January 29, 2026
概括
研究人员使用生物信息学发现了WP516,一种新的硫酶酶. 这种酶有效地循环各种四甲,扩大产生循环四甲 (CTP) 的可能性.
科学领域:
- 生物化学 生物化学
- 生物信息学是一种生物信息学.
- 自然产品的合成自然产品的合成
背景情况:
- 循环四甲 (CTP) 是具有多种生物活性的有价值的天然产品.
- 合成CTP是具有挑战性的,因为环应变和当前化学方法的局限性.
- 为了更广泛的基质范围,人们正在寻求CTP合成的酶方法.
研究的目的:
- 通过使用生物信息学引导的方法,发现用于高效四甲循环的新型酶.
- 鉴定和描述一种能够产生多种循环四类酶的铁酶.
- 了解酶的广泛基质特异性背后的机制.
主要方法:
- 生物信息学分析了神秘的非核糖体合成酶 (NRPS) 基因集群.
- 在基中预测和识别素结合型硫酶 (PBP-TE).
- 鉴定出的酶 (WP516) 与各种四基质的生物化学表征.
- 结构和计算分析,包括AlphaFold建模,共价对接,分子动力学和突变研究.
主要成果:
- 第一个由生物信息学指导的发现,是从一个神秘的基因集群中发现一种用于化循环的化酶 (WP516).
- WP516证明了对广泛的四甲基质的有效循环.
- 与此前已知的四类环酶Ulm16相比,WP516具有显著更广泛的基质范围.
- 结构和计算分析为WP516的广泛基板接受提供了洞察力.
结论:
- 开发的生物信息学工作流程对于发现参与循环的新型酶是有效的.
- WP516是一种强大的生物催化剂,用于生产各种头到尾的循环四甲.
- 这一发现为循环和生物催化剂CTP生产中的酶发现提供了新的策略.
相关概念视频
Factors Affecting Protein-Drug Binding: Protein-Related Factors
556
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
556
The Equilibrium Binding Constant and Binding Strength
15.0K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
15.0K
Drug Distribution: Plasma Protein Binding
8.8K
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
8.8K
Protein-Drug Binding: Determination Methods
648
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
648
Conserved Binding Sites
5.2K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
5.2K
Ligand Binding and Linkage
5.6K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.6K

